If You Build It, They Will Come: Cancer Care in Rwanda

by Barbara Virchick

On July 18, 2012, a Cancer Center of Excellence opened in Butaro, Rwanda, as a collaboration between Partners In Health and Dana-Farber/Brigham and Women’s Cancer Center. I was fortunate to have been there during this exciting time, working as part of a three-month fellowship to help train the nursing staff to care for Rwandan cancer patients.

I don’t think any of us were prepared for the explosion of patients who would arrive during the first month we were open.

Read more

Why Nursing? One Oncology Nurse Explains

Laura Ma remembers the moment nursing chose her.

Upon earning her bachelor’s degree in art and sociology at the University of California Santa Cruz, she received her emergency teaching credential because of critical teacher shortages in the state. Three years later, she “felt like she needed something more,” Ma says. After relocating to Boston, she worked as a receptionist at Planned Parenthood. “I witnessed the amazing work the nurses did there,” she says. “Seeing education applied in a health care setting – that is when I knew I wanted to be a nurse.”

Read more

Stem Cell Transplant vs. Bone Marrow Transplant: What’s the Difference?

A stem cell transplant can be referred to as a bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) or umbilical cord blood transplantation (UCBT), depending on the source of the cells that are transplanted. In other words, the only real distinction between a bone marrow transplant and a stem cell transplant in the method … Read more

What Evolution Can Teach Us About Cancer

Like wombats and wildebeests, cancer cells are continually adapting to their environment. If that environment includes drugs meant to kill cancer cells, some cells may adapt so well, they eventually gain the ability to grow and divide in spite of those drugs – a process known as drug resistance. The result can be a resurgence of tumors that once were held in check by treatment.

Read more

Nine Tips for Talking To Kids About Cancer

 Helping a loved one face cancer is never easy, but the challenge is especially daunting when the patient is your own child. Our clinicians at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center work with pediatric cancer patients and their families every day. Lisa Diller, MD, Anna Muriel, MD, and Jorge Fernandez, LCSW – offer these 9 tips for talking with your children about their illness.           

Read more

When a Celebrity Has Breast Cancer

by Erica Mayer, MD, MPH 

In 1974, when First Lady Betty Ford announced that she had undergone a mastectomy for breast cancer, it was a turning point in people’s willingness to talk about the disease. Prior to that, discussing cancer of any type, even with one’s family or friends, was often taboo. The First Lady’s openness about her cancer helped create a space in which women felt more comfortable talking about their experience – and about being screened for the disease.

Read more

Why Do Scientists Use Zebrafish to Study Cancer?

Cancer scientists use a wide variety of techniques to study the growth and development of tumor cells. Laboratory research often focuses on individual cells or tissue samples, but to learn how cancers grow and respond to therapies in living organisms, scientists rely on other experimental models. In recent years, zebrafish have become the model of choice for studying many cancer types. Dana-Farber’s A. Thomas Look, MD, who uses zebrafish in his own work, explains why.

Read more

Breast Cancer, Aromatase Inhibitors, and Bone Density

Aromatase inhibitors (AIs), such as Arimidex, Aromasin, and Femara, have proven to be more effective than previous hormonal treatments for treating both early and advanced breast cancer in post-menopausal women whose tumors are dependent on estrogen. Compared with tamoxifen, these drugs are less likely to cause blood clots or raise the risk of endometrial cancer. As a result, AIs are used both in patients with early breast cancer and in those with metastatic disease.

Read more

Faces of Childhood Cancer: Steven Clifford

Steven Clifford is an 18-year-old osteosarcoma survivor. A Boston native, he starts college at the University of California, San Diego this month. This is his story.

Life is made up of many difficult decisions. However, imagine my surprise when I had to make a tough and potentially life changing decision at the young age of 11. Up until then, I just was an average child who couldn’t wait to get out of school to play any sport imaginable with his friends.

Read more

How to Build a Support Network

By Lola Baltzell

People often ask me: How do you manage to live with metastatic breast cancer? One of the most important strategies for me has been building a support network.

My diagnosis of breast cancer that had already spread to my bones came out of the blue. I had a normal mammogram 13 months earlier, and no known risk factors. So when I heard the news in August 2008, my first impulse was to reach out for support.

Read more